These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9598580)

  • 1. A canine model of familial mammary gland neoplasia.
    Schafer KA; Kelly G; Schrader R; Griffith WC; Muggenburg BA; Tierney LA; Lechner JF; Janovitz EB; Hahn FF
    Vet Pathol; 1998 May; 35(3):168-77. PubMed ID: 9598580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
    Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
    Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
    Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
    Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
    Klopfleisch R; Klose P; Gruber AD
    Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
    Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
    Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: An immunohistochemical and prognostic study.
    Dolka I; Król M; Sapierzyński R
    Res Vet Sci; 2016 Apr; 105():124-33. PubMed ID: 27033920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
    Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
    Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
    Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
    Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 expression associated with canine mammary tumors.
    Zuccari DA; Castro R; Gelaleti GB; Mancini UM
    Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors.
    Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Miyoshi N; Hayashi T
    J Vet Med Sci; 1999 Jan; 61(1):27-32. PubMed ID: 10027159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
    Dutra AP; Granja NV; Schmitt FC; Cassali GD
    Braz J Med Biol Res; 2004 Nov; 37(11):1673-81. PubMed ID: 15517084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary gland tumors in male dogs.
    Saba CF; Rogers KS; Newman SJ; Mauldin GE; Vail DM
    J Vet Intern Med; 2007; 21(5):1056-9. PubMed ID: 17939564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
    Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
    Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.